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INTRODUCTION
Ewing’s sarcoma is a highly malignant tumor of osseous or
non-osseous origin. It is the second most common bone tumor
of childhood and adolescence. More than half of all patients
present in the second decade of life and is uncommon in
adults older than 30 years. There is a male preponderance of
approximately 1.5:1. Ewing’s sarcoma rarely occurs in black
and Chinese children.1
The Ewing’s sarcoma usually arises in the metaphysis or
diaphysis of the long bones of extremities. Pelvic area, ribs
and scapulae are less frequent sites although any bone can be
involved. The lungs, bones and bone marrow are the most
common sites of metastasis.1, 2 This report describes a case
of extra osseous Ewing sarcoma of the pelvic in teen-age
female.
CASE REPORT
A 15-year-old Pakistani girl presented in the clinic in August
2004 with lower abdominal pain, palpable abdominal mass
and left leg weakness. Since 2 months, the abdomen had
increased in size with lower abdominal discomfort and
significant loss of appetite and weight.  It was followed, a few
weeks later, by sudden onset of left lower limb weakness and
muscular atrophy with difficulty in walking and severe pain
starting from back of gluteal region to mid calf.
She was dehydrated and emaciated. Her vital signs and
general examination were normal. On abdominal examination,
a mass was palpated from left lateral pelvic wall, reaching to
just below the epigastrium, which was firm, well circumscribed
and non-tender. Liver and spleen were not palpable and
shifting dullness was absent. There was no lymphadenopathy.
Specific neurological examination of the lower limbs revealed
left leg muscular atrophy with less sensory motor power and
foot drop. 
Complete blood counts, coagulation profile, renal and liver
functions were normal. Laboratory investigation revealed
hemoglobin of 10.9 gm/dl, hematocrit of 40.1%, total leukocyte
count of 10,000/mm3, platelet count of 275,000 /mm3 and ESR
of 39 mm/hr.  Tumor markers CA-125          (73.63 iu/ml) and
LDH (1100 iu/L) were raised. Serum human
choriongonadotrophin and alpha feto-protein were in normal
range (<2.010 and 1.76 respectively). Chest X-ray showed
no evidence of pleural effusion or any other  active lesion. 
Ultrasonography of liver, spleen, pancreas and gall-bladder
were normal. No para-aortic lymph nodes were seen. Due to
pressure effect of the mass, there was  bilateral pelvicalyceal
dilatation by 1 cm. A solid mass of 17.9 x 9.9 cm was seen in
lower abdomen with possibility of uterine sarcoma. Both
ovaries were normal.
Doppler ultrasound showed high vascular tumor with
possibility of sarcoma. MRI  of pelvis revealed a solid mass of
18.0 x 12.0 cm, arising from pelvis and left adnexa, involving
the upper part of vagina, obturator internus and gluteus
minimus  muscles   (Figure 1a  and 1b).
Because of retroperitoneal nature of tumor and suspicion of
uterine sarcoma laparotomy was performed.  Pelvic peritoneal
washing were obtained but there was no free fluid in peritoneal
cavity.  A large retroperitoneal mass of 18 x12 cm was arising
from left lateral pelvic wall to hollow of sacrum, and densely
adherent to the posterior wall of uterus.  Both ovaries were
normal.  
Due to high vascularity of tumor, partial debulking was
performed.  Hemostasis was secured. Frozen section of
specimen revealed malignant undifferentiated anaplastic
sarcoma with differential diagnosis of Ewing’s sarcoma or
lymphoma.  Postoperatively, she was kept in Special Care Unit
(SCU) and received packed cell transfusion and further
hospital course was unremarkable.
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Figure 1a and 1b:  T2 weighted MRI showing the pelvis tumour extent in sagittal
(a) and  (b) axial sections.
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The diagnosis of Ewing’s sarcoma was supported by the
identification of glycogen within the tumor cells and by the
demonstration of the MIC2 gene product on the tumor cell
membrane. The immunohistochemical marker (vimentin and
S-100) were positive. Bone scan and bone marrow biopsy
were performed, which were negative for metastasis.
Emphasis was given on limb physiotherapy with various
exercises.  On 6th postoperative day, she received  first cycle
of multi-agent chemotherapy of IVAC (Ifosfamide, vincristine,
adriamycin, cyclophosphamide).  She was discharged on 10th
postoperative day.  On follow-up visit, the pelvic mass was
regressing, so patient and her parents were counseled about
compliance for further chemotherapy cycles.  After 9 cycles of
IVAC, tumor was not palpable abdominally. A repeat
ultrasound revealed no pelvic mass. On follow up visits, she
was doing well.
DISCUSSION 
Ewing’s sarcoma is the second most common malignant bone
tumor in young age group, and is commonly diagnosed in the
second decade with male preponderance. The annual
incidence rate averages less than 2 cases per million
children.1,3 In addition to primitive neuroectodermal tumor of
the uterus and mesenchymal lesion of the uterine cervix, there
are reports of pelvic mass of osseous and non-osseous origin
in either gender. 4-6
A delay in early symptoms and diagnosis is quite common,
particularly of pelvic tumors in which this mass is not palpable
until it is quite large.1,7 The most important and earliest
symptom is pain, which may radiate to the limbs, especially
with tumor in the vertebral or pelvic region. Neurological signs
such as nerve root sign or cord compression are present in
one-half of patients with the involvement of axial skeleton.
Patient with metastatic   Ewing’s sarcoma may also present
with systemic signs and symptoms such as weight loss and
fever. 1
This patient presented with lower abdominal pain, large
palpable pelvic mass, left leg weakness, weight loss, and
fever.  Laboratory studies in this case showed an increased
erythrocyte sedimentation rate, elevated lactate
dehydrogenate (LDH), and absence of metastasis. The major
prognostic factors in Ewing’s sarcoma are: age, site (pelvis,
sacrum), volume of tumor (more than 10 cm), and presence of
metastasis at the time of diagnosis.7
MRI imaging is preferred method in assessing the involvement
of soft tissue and bone marrow. Molecular and cytogenetic
analysis should be considered as the standard practice in the
diagnostic evaluation of Ewing’s sarcoma.1
With the advent of modern chemotherapy, control of local
disease has become more important with increased long-term
survival rates. A recent study of Ewing’s sarcoma of the pelvis
also found an increased 5 years survival rate for patients who
had resection of their primary tumor. The patients with non-
metastatic Ewing’s sarcoma, treated with chemotherapy and
operative resection had a 75% overall 5-year survival rate,
compared with 25% overall survival rate where surgery was
not performed.  Surgery eliminates the residual tumor that are
left behind after chemo- or radiation therapy.4,7
The development of multi-agent chemotherapy has increased
the survival rate of patients with Ewing’s sarcoma from 10 %
to 70%. More recently, Ifosfamide has emerged as a very
effective chemotherapeutic agent, especially in patients
resistant to other drugs. With multidisciplinary treatment, long-
term survival can be achieved in 70 to 80% of patients
presenting with non metastatic disease.7-9 In this case,
laparotomy was planned first due to the suspicion of uterine
sarcoma, and the mass being retroperitoneal. With this
approach, not only histological confirmation of Ewing’s
sarcoma was possible, but also more than  half of the tumor
volume was reduced and further tumor reduction was done by
means of multiagent chemotherapy.
Surgical resection, multiagent chemotherapy and radio-therapy
are  the mainstay of treatment. The treatment plan should be
individualized for each patient, which should be based on age,
location, stage, size of the tumor and response to therapy. 
REFERENCES
1. Strauss LG. Ewing’s sarcoma, [online]2005 [cited 2006 Nov 2]
Available from URL: http: // www.emedicine.com/radio/topic 275 htm. 
2. Primitive neuroectodermal tumors and related lesions. In: Weiss SW,
Goldblum JR, (edi). Enzinger and Weiss’s soft tissue tumors. 4th ed. St
Louis: Mosby, 2001: 1265-321.
3. Shah SH, Muzaffar S, Soomro IN, Pervez S, Hasan SH.  Clinico –
morphological pattern and frequency of bone cancer. J Pak Med Assoc
1999; 49: 110-2. 
4. Gostout BS, Lindor NM, DiMarco CS, Peethambaram PP, Clayton AC.
Pelvic primitive neuroectodermal tumor associated with a cluster of
small round cell tumors: case report and review of current literature.
Gynecol Oncol 2003; 91: 247-53.
5. Karseladze AI, Filipova NA, Navarro S, Llombart–Bosch A. Primitive
neuroectodermal tumor of the uterus: a case report.            J Reprod
Med 2001; 46: 845-8.
6. Frassica FJ, Frassica DA, Pritchard DJ, Schomberg PJ, World LE, Sim
FH. Ewing’s sarcoma of the pelvis. Clinicopathological features and
management. J Bone Joint Surg Am 1993; 75: 1457-65.
7. Vlasak R, Sim FH. Ewing’s sarcoma. Orthop Clin North Am 1996; 27:
591-603.
8. Aslam E, Imran M. Faridi NM. Bilateral parietal extradural metastatic
Ewing’s sarcoma simulating acute epidural hematoma. J Coll
Physicians Surg Pak 2006; 16: 543-4.
9. Approach to the diagnosis of soft tissue tumor. In: Weiss SW, Goldblum
JR, (edi). Enzinger and Weiss’s soft tissue tumors. 4th ed. St Louis:
Mosby, 2001: 189-97.
Tahira Naru, Fauzia Haq Nawaz and Javed Rizvi 
l l l l lO l l l l l
